Filing Details
- Accession Number:
- 0001415889-21-006216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-23 20:16:11
- Reporting Period:
- 2021-12-21
- Accepted Time:
- 2021-12-23 20:16:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1597341 | Alan Robert Schueren | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-21 | 5,000 | $13.01 | 26,517 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-21 | 2,707 | $92.59 | 23,810 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-21 | 2,293 | $93.43 | 21,517 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-21 | 3,671 | $92.58 | 65,612 | No | 4 | S | Indirect | Robert A Schueren & Deborah A Schueren Rev Trust |
Common Stock | Disposition | 2021-12-21 | 3,329 | $93.43 | 62,283 | No | 4 | S | Indirect | Robert A Schueren & Deborah A Schueren Rev Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | Robert A Schueren & Deborah A Schueren Rev Trust |
No | 4 | S | Indirect | Robert A Schueren & Deborah A Schueren Rev Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-12-21 | 5,000 | $0.00 | 5,000 | $13.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
48,477 | 2029-01-10 | No | 4 | M | Direct |
Footnotes
- The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.10 to $93.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.11 to $93.62 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.09 to $93.06 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The Reporting Person is a trustee of the Robert A Schueren & Deborah A Schueren Rev Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.11 to $93.62 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option shares vest over four years. 25% of the option shares vested and became exercisable on January 7, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.